the ai bio wars are heating up this will be the next big thing in ai what's been happening in case you missed it: > oct 2025 - anthropic launches claude for life sciences > apr 2026 - anthropic buys coefficient bio (reportedly ~$400m, <10 ex-genentech scientists) > apr 2026 - openai launches gpt-rosalind, it's bio model > may 2026 - isomorphic labs (alphabet's ai drug co, deepmind spinout) raises $2.1b and eyes first human trials > jun 2026 - nobel laureate john jumper (alphafold) leaves deepmind for anthropic > sep 2026 - anthropic confirms its own wet lab in the bay area > oct 20 - openai acquires orchestra bio (ai agents for trials, timelines, cros) and folds it into rosalind > oct 27 - anthropic reveals acquisition of mithril: a 1-person biotech run on claude. starts in-house drug programs. human trials possible by late 2028 frontier labs are becoming biotech labs. extremely exciting times ahead